<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37098546</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1546-0096</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>25</Day></PubDate></JournalIssue><Title>Pediatric rheumatology online journal</Title><ISOAbbreviation>Pediatr Rheumatol Online J</ISOAbbreviation></Journal><ArticleTitle>Antibodies to histone in the pediatric population: a retrospective chart review.</ArticleTitle><Pagination><StartPage>40</StartPage><MedlinePgn>40</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">40</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12969-023-00821-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Antibodies to histone have been associated in the adult literature with systemic lupus erythematosus(SLE) and drug induced lupus(DILE). Little data is available regarding the spectrum of pathology that antibodies to histone encompass in the pediatric population. Prior studies suggest an association with SLE, juvenile idiopathic arthritis(JIA), uveitis and linear scleroderma.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patient charts were reviewed that contained positive anti-histone antibody testing during a consecutive three year period. Patient diagnosis along with the presence of: anti-histone antibody titer, ANA, and the presence of other autoantibodies to SSA, SSB, Sm, RNP, dsDNA and chromatin were obtained. The frequency of SLE, JIA and DILE was further investigated in specific subsets.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">139 individual charts were reviewed containing 41 different diagnoses. The most common diagnosis was hypermobility arthralgia with 22 patients. The most frequent rheumatologic diagnosis was JIA(nonsystemic) with 19. 13 patients in this study were diagnosed with SLE and 2 with DILE. 18 patients had other autoantibody production, of these, 11 had SLE or DILE. Only one of 62 patients with a weak antihistone antibody titer(1.0-1.5) was diagnosed with SLE. When strong titers are present(&gt;&#x2009;2.5), the antihistone antibody test was associated with a greater than 50% incidence of an underlying rheumatologic disease and ten times higher incidence of SLE than a weak titer. In regards to the frequency of SLE, there was a statistically significant difference between weak and moderate titers and between weak and strong titers.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The presence of anti-histone antibody was observed in a variety of diagnoses in the pediatric population. Overall, the presence of anti-histone antibodies appears to have poor diagnostic utility for any specific condition. However, diagnostic utility for SLE does appear to improve with higher titers, when combined with other autoantibody positivity. Strength of titer did not appear to be a factor for JIA, but was the most frequently observed rheumatologic disease in this study.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Justice</LastName><ForeName>C Matt</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Division of Rheumatology and Pediatric Rheumatology, Saint Louis University School of Medicine, St. Louis, MO, USA. Justice74@marshall.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Terry L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Division of Rheumatology and Pediatric Rheumatology, Saint Louis University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pediatr Rheumatol Online J</MedlineTA><NlmUniqueID>101248897</NlmUniqueID><ISSNLinking>1546-0096</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006657">Histones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000974">Antibodies, Antinuclear</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006657" MajorTopicYN="N">Histones</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000974" MajorTopicYN="N">Antibodies, Antinuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Drug induced lupus(DILE)</Keyword><Keyword MajorTopicYN="N">Histone</Keyword><Keyword MajorTopicYN="N">Juvenile idiopathic arthritis(JIA)</Keyword><Keyword MajorTopicYN="N">Pediatric</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus(SLE)</Keyword><Keyword MajorTopicYN="N">Uveitis</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>26</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>25</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37098546</ArticleId><ArticleId IdType="pmc">PMC10131474</ArticleId><ArticleId IdType="doi">10.1186/s12969-023-00821-y</ArticleId><ArticleId IdType="pii">10.1186/s12969-023-00821-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gioud M, Kaci MA, Monier JC. Histone antibodies in systemic lupus erythematosus. A possible diagnostic tool. Arthr Rhuem. 1982;25(4):407&#x2013;13. doi: 10.1002/art.1780250408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780250408</ArticleId><ArticleId IdType="pubmed">6978717</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritzler MJ, Tan EM. Antibodies to Histones in Drug-Induced and Idiopathic Lupus Erythematosus. J Clin Invest. 1978;62(3):560&#x2013;7. doi: 10.1172/jci109161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci109161</ArticleId><ArticleId IdType="pmc">PMC371800</ArticleId><ArticleId IdType="pubmed">357449</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen MG, Pollard KM, Webb J. Antibodies to histones in systemic lupus erythematosus: prevalence, specificity, and relationship to clinical and laboratory features. Ann Rheum Dis. 1992;51(1):61&#x2013;6. doi: 10.1136/ard.51.1.61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.51.1.61</ArticleId><ArticleId IdType="pmc">PMC1004620</ArticleId><ArticleId IdType="pubmed">1540040</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein A, Greenberg M, Halbert S, Kramer L, Barland P. The clinical application of an ELISA technique for the detection of antihistone antibodies. J Rheumatol. 1986;13(2):304&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">3522897</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilliam BE, Ombrello AK, Burlingame R, Pepmueller PH, Syed RH, Moore TL. Measurement of autoantibodies in pediatric- and adolescent-onset systemic lupus erythematosus and their significant relationship with disease-associated manifestations. Pediatr Rheumatol. 2012;10(S1). 10.1186/1546-0096-10-s1-a24.</Citation><ArticleIdList><ArticleId IdType="pubmed">22177108</ArticleId></ArticleIdList></Reference><Reference><Citation>Malleson PN, Petty RE, Fung M, Candido EPM. Reactivity of antinuclear antibodies with histones and other antigens in juvenile rheumatoid arthritis. Arthritis Rheum. 1989;32:919&#x2013;23. doi: 10.1002/j.2326-5205.1989.tb00025.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.2326-5205.1989.tb00025.x</ArticleId><ArticleId IdType="pubmed">2473758</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauls JD, Silverman E, Laxer RM, Fritzler MJ. Antibodies to histones H1 and H5 in sera of patients with juvenile rheumatoid arthritis. Arthritis Rheum. 1989;32(7):877&#x2013;83. doi: 10.1002/j.2326-5205.1989.tb00019.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.2326-5205.1989.tb00019.x</ArticleId><ArticleId IdType="pubmed">2787640</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostensen M, Fredriksen K, Kass E, Rekvig OP. Identification of antihistone antibodies in subsets of juvenile chronic arthritis. Ann Rheum Dis. 1989;48(2):114&#x2013;7. doi: 10.1136/ard.48.2.114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.48.2.114</ArticleId><ArticleId IdType="pmc">PMC1003695</ArticleId><ArticleId IdType="pubmed">2784658</ArticleId></ArticleIdList></Reference><Reference><Citation>Leak AM, Woo P. Juvenile chronic arthritis, chronic iridocyclitis, and reactivity to histones. Ann Rheum Dis. 1991;50(9):653&#x2013;7. doi: 10.1136/ard.50.9.653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.50.9.653</ArticleId><ArticleId IdType="pmc">PMC1004515</ArticleId><ArticleId IdType="pubmed">1929592</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordal EB, Berntson L, Aalto K, et al. Histone antibodies as a biomarker of uveitis in JIA. Pediatr Rheumatol. 2014;12(1). 10.1186/1546-0096-12-s1-o4.</Citation></Reference><Reference><Citation>El-Azhary RA, Aponte CC, Nelson AM, Weaver AL, Homburger HA. Antihistone antibodies in linear scleroderma variants. Int J Dermatol. 2006;45(11):1296&#x2013;9. doi: 10.1111/j.1365-4632.2006.02891.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-4632.2006.02891.x</ArticleId><ArticleId IdType="pubmed">17076709</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>